This site is intended for Healthcare Professionals only.

Rowlands Pharmacy acquires 30 LloydsPharmacy branches in Scotland

Date:

Share post:

Rowlands Pharmacy has announced that it has acquired 30 LloydsPharmacy branches in Scotland.

The community pharmacy group owned by the wider Numark network now has over 70 directly owned branches in Scotland.

Nigel Swift, managing director of Rowlands Pharmacy, said: “This is a significant investment in growing our network north of the border and further reinforces our presence in Scotland delivering outstanding patient care services, advice and support. We welcome our new colleagues into the Numark family.”

For many years, the Scottish government has supported community pharmacy at the forefront of providing NHS care which people want, need and value with a commitment that has delivered for patients and the NHS, he said.

“We are investing in Scotland in the expectation that support from the Scottish government will continue in the years ahead to recognise the critical role of community pharmacy at the beating heart of healthcare provision from illness prevention through to long-term condition management,” Swift added.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Darzi report reveals NHS is in critical condition, pharmacy bodies urge immediate action

Pharmacy organisations are hopeful that the Darzi report will prompt ministers to take swift action to tackle the...

RPS proposes transition to Royal College, seeks feedback from pharmacy community

The proposed changes will need approval from RPS members through a vote, which is anticipated in early 2025 The...

COVID-19 Inquiry: RPS calls for greater recognition and support for pharmacists

Despite their crucial role during the pandemic, community pharmacy was often an afterthought in government planning, guidance and...

Exclusive: BGMA chief executive on how CPTPP accession will affect UK medicine manufacturers

CPTPP membership could attract more suppliers to the UK market, thereby reduce drug shortage risks and lower prices...